22-29260229-T-G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.

The NM_012265.3(RHBDD3):​c.992A>C​(p.Gln331Pro) variant causes a missense change. The variant allele was found at a frequency of 0.0000131 in 1,600,684 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000076 ( 0 hom. )

Consequence

RHBDD3
NM_012265.3 missense

Scores

2
9
8

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.97

Publications

0 publications found
Variant links:
Genes affected
RHBDD3 (HGNC:1308): (rhomboid domain containing 3) Predicted to enable serine-type endopeptidase activity. Predicted to be involved in proteolysis. Predicted to act upstream of or within several processes, including liver development; negative regulation of natural killer cell activation; and positive regulation of protein catabolic process. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RHBDD3NM_012265.3 linkc.992A>C p.Gln331Pro missense_variant Exon 7 of 7 ENST00000216085.12 NP_036397.1 Q9Y3P4A0A024R1J2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RHBDD3ENST00000216085.12 linkc.992A>C p.Gln331Pro missense_variant Exon 7 of 7 1 NM_012265.3 ENSP00000216085.7 Q9Y3P4
RHBDD3ENST00000413137.6 linkn.*568A>C non_coding_transcript_exon_variant Exon 7 of 7 5 ENSP00000399550.2 F8WFA9
RHBDD3ENST00000413137.6 linkn.*568A>C 3_prime_UTR_variant Exon 7 of 7 5 ENSP00000399550.2 F8WFA9

Frequencies

GnomAD3 genomes
AF:
0.0000657
AC:
10
AN:
152208
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000225
AC:
5
AN:
221964
AF XY:
0.0000166
show subpopulations
Gnomad AFR exome
AF:
0.000300
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000759
AC:
11
AN:
1448476
Hom.:
0
Cov.:
30
AF XY:
0.00000695
AC XY:
5
AN XY:
719392
show subpopulations
African (AFR)
AF:
0.000270
AC:
9
AN:
33362
American (AMR)
AF:
0.00
AC:
0
AN:
42212
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25740
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39260
South Asian (SAS)
AF:
0.0000119
AC:
1
AN:
84104
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51784
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5750
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1106396
Other (OTH)
AF:
0.0000167
AC:
1
AN:
59868
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000657
AC:
10
AN:
152208
Hom.:
0
Cov.:
33
AF XY:
0.0000807
AC XY:
6
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41462
American (AMR)
AF:
0.00
AC:
0
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68020
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.445
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000745
Hom.:
0
Bravo
AF:
0.0000869
ESP6500AA
AF:
0.000683
AC:
3
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000248
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 05, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.992A>C (p.Q331P) alteration is located in exon 7 (coding exon 5) of the RHBDD3 gene. This alteration results from a A to C substitution at nucleotide position 992, causing the glutamine (Q) at amino acid position 331 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.93
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.090
CADD
Pathogenic
27
DANN
Uncertain
0.99
DEOGEN2
Benign
0.15
T
Eigen
Uncertain
0.54
Eigen_PC
Uncertain
0.55
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.86
D
M_CAP
Benign
0.081
D
MetaRNN
Uncertain
0.51
D
MetaSVM
Benign
-0.82
T
MutationAssessor
Benign
0.90
L
PhyloP100
5.0
PrimateAI
Uncertain
0.69
T
PROVEAN
Benign
-1.7
N
REVEL
Uncertain
0.38
Sift
Uncertain
0.0040
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.61
MVP
0.64
MPC
0.086
ClinPred
0.22
T
GERP RS
4.7
Varity_R
0.70
gMVP
0.83
Mutation Taster
=45/55
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144254533; hg19: chr22-29656218; API